Abstract
Different cervical dystonia (CD) patterns exhibited comparable efficacy of Botulinum Toxin Type A (BTX-A) due to appropriate selection of dystonic muscles aided by SPECT and EMG. This indicates that by employing multifaceted approaches to identify dystonic muscles, favorable outcomes can be achieved even in complex cases.
Introduction
Cervical Dystonia (CD) is a neurological disorder characterized by involuntary muscle contractions that cause abnormal neck and head movements. While Botulinum Toxin Type A (BTX-A) is the gold-standard treatment, clinical outcomes vary significantly between patients. The challenge often lies in the "Col-Cap" classification system, which distinguishes between movements of the head (caput) and the neck (collis). Many patients present with "complex" types—combinations of multiple postural patterns. Historically, these complex cases were thought to be more resistant to treatment. This study sought to determine if advanced diagnostic tools could bridge the efficacy gap between simple and complex CD patterns.
Methods
This retrospective study analyzed 252 patients treated at the Neurotoxin Research Center at Tongji Hospital between 2017 and 2022. Patients were categorized into "Simple" (31.0%) and "Complex" (69.0%) types. The diagnostic and treatment protocol involved:
- SPECT Imaging: Patients underwent 99mTc-MIBI SPECT scans to identify "hot spots" of high metabolic activity in dystonic muscles.
- EMG Guidance: Candidate muscles identified by SPECT and clinical evaluation were tested via electromyography. BTX-A was injected only if EMG confirmed abnormal electrical activity.
- Evaluation: Efficacy was measured four weeks post-injection using subjective clinical improvement rates and reduction in the Tsui score.
Results
The most significant finding was that complex CD patients achieved the same percentage of improvement as simple cases, despite starting with higher baseline severity.
- Subjective Improvement: No significant difference was found between groups. Simple types reported 63.5% ± 20.6% improvement, while complex types reported 59.9% ± 22.2% ($p=0.247$).
- Tsui Score Reduction: Reduction rates were nearly identical: 52.4% for simple vs. 49.6% for complex ($p=0.556$).
Functional imaging also revealed that muscles like the levator scapulae and scalenus were frequently active in "torticaput" (head rotation) patterns, highlighting the necessity of SPECT over purely anatomical assumptions.
Discussion
The results indicate that the complexity of a patient's posture does not inherently limit the effectiveness of botulinum toxin. Instead, the difficulty lies in accurate muscle selection. By combining clinical expertise with SPECT and EMG, clinicians can level the playing field for complex cases. While complex cases required slightly higher average doses, the safety profile remained typical for BTX-A, with mild adverse events such as local pain and transient weakness.
Conclusion
Precision targeting using a multifaceted diagnostic approach ensures favorable outcomes in cervical dystonia treatment, regardless of postural complexity. Future work incorporating ultrasound guidance may further refine these results for deep cervical muscles.
Summary updated